The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell Carcinoma
Status:
Recruiting
Trial end date:
2025-05-25
Target enrollment:
Participant gender:
Summary
The investigators want to assess the safety and efficacy of using intralesional 5-FU for the
management of different types of BCC (including all the types EXCEPT the infiltrative one),
by estimating different outcomes after the intralesional administration of 5-FU to BCC
patient. Patients are randomly selected from the outpatient dermatologic clinic in the Aleppo
University Hospital (AUH) over a period of 12 months and then these patients are followed up
over another 12 months.